Organon
OGN13.5550.04% ( +0.005 )
Organon (OGN)
Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest...
- Open
- 13.545
- High
- 13.560
- Low
- 13.540
- Prev. Close
- 13.550
- Volume
- 520.04K
- Turnover
- 7.05M
- Avg Price
- 13.552
- Bid/Ask Ratio
- --
- Amplitude
- 0.15%
- 52wk High
- 13.600
- Volume Ratio
- 0.32
- Turnover Ratio
- 0.20%
Organon Analyst Rating
View MoreForecast & Rating
Jun 23, 2026Price forecast
$11.25-17.00%
Forecast & RatingHold
5analysts
- Strong buy0.00%
- Buy0.00%
- Hold80.00%
- Sell0.00%
- Strong sell20.00%
News
- Quartr · 1 hour ago
SUNPHARMA: Strong Q1 growth driven by India and innovation, while U.S. generics faced headwinds
- Quartr · 3 hours ago
OGN: Revenue and net income fell as biosimilar growth offset declines in core brands; Sun Pharma deal advances
- TradingView · 4 hours ago
Organon & Co. 2026: Revenue $1.56B, EPS $0.4— 10-Q Summary
- Market Beat · 6 hours ago
Orographic Financial Advisors LLC Acquires New Holdings in Organon & Co. $OGN
- Quartr · 6 hours ago
SUNPHARMA: Q1FY27 sales rose 10.1% to ₹151,836 million, with net profit at ₹28,948 million and strong India growth
- StockTitan · 12 hours ago
Organon Announces Quarterly Dividend | OGN Stock News
